Cervarix and cervical cancer: why protection against HPV 16 and 18 matters
Updated: 1 day ago
Reviewed by Dr Joel Lim, MB CHB(UK), PG Diploma Dermatology
Full Singapore Medical Council Registration, Resident Physician, Kingsway Medical.
Originally published: 16 January 2026
Updated: 20 November 2026
Two HPV types are responsible for a substantial share of cervical cancer. HPV 16 and 18 together cause approximately 70% of cervical cancers, according to Singapore’s Ministry of Health. [1]
Cervarix® targets these two types. Its role in prevention is significant because the importance of a vaccine depends on the diseases its targets cause, as well as the number of types covered.
How a common infection can lead to serious disease
Most HPV infections clear without causing lasting problems. In some people, however, a persistent infection with a cancer causing type leads to changes in the cells of the cervix. These changes may progress to cancer if they are not identified and managed. [2]
An HPV infection or abnormal screening result does not automatically mean cancer. It does mean that appropriate advice and follow-up matter.
What Cervarix is designed to prevent
Singapore’s registered product information describes Cervarix as a vaccine for preventing persistent HPV 16 and 18 infection, precancerous cervical lesions and cervical cancer caused by these types. [3]
Preventing the initial infection can help interrupt the process that leads to disease. Vaccination is therefore most useful before exposure.
It does not treat an existing HPV infection, remove abnormal cervical cells or replace treatment recommended after an abnormal screening result. [4]
Why vaccination should not wait for a health scare
A preventive appointment gives you time to review your records, discuss suitability and plan the required doses.
If you are already sexually active, do not assume that vaccination is automatically pointless. Your doctor can assess your previous doses and circumstances. Equally, a completed course should not be repeated simply because another vaccine is available.
Cervarix remains an alternative in Singapore’s national HPV vaccination arrangements when Gardasil 9 is added from January 2027. [1]
Keep cervical screening in the plan
Cervarix does not cover every HPV type associated with cervical cancer. Regular screening remains important for eligible women after vaccination. [4]
Screening may identify infection or abnormal cells before symptoms develop. Following up on an abnormal result is part of prevention, even when you feel completely well.
At your appointment, bring both your vaccination history and the date of your last cervical screening. This allows the discussion to address your overall protection.
Take a practical step towards prevention
For suitable people who need HPV vaccination, Cervarix can help protect against two major causes of cervical cancer. Book a review at Kingsway Medical to discuss vaccination, course completion and the screening appropriate for you.
.png)